KD Logo

Insider Selling: Ho Carole, Denali Therapeutics Inc [DNLI] Chief Medical Officer divested 12,255 shares

NUE

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Denali Therapeutics Inc shares valued at $247,796 were sold by Ho Carole on Jan 06 ’25. At $20.22 per share, Ho Carole sold 12,255 shares. The insider’s holdings dropped to 178,580 shares worth approximately $3.84 million following the completion of this transaction.

Also, Ho Carole sold 2,907 shares, netting a total of over 60,495 in proceeds. Following the sale of shares at $20.81 each, the insider now holds 175,673 shares.

Before that, Schuth Alexander O. had sold 12,255 shares from its account. In a trade valued at $247,796, the COFO and Secretary traded Denali Therapeutics Inc shares for $20.22 each. Upon closing the transaction, the insider’s holdings decreased to 12,255 shares, worth approximately $5.32 million.

As published in their initiating research note from Robert W. Baird on January 07, 2025, Denali Therapeutics Inc [DNLI] has been an Outperform and the price target has been revised to $31. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in early January. As of December 16, 2024, Stifel has increased its “Hold” rating to a “Buy” for DNLI.

Analyzing DNLI Stock Performance

During the last five days, there has been a surge of approximately 1.51%. Over the course of the year, Denali Therapeutics Inc shares have jumped approximately 5.50%. Shares of the company reached a 52-week high of $22.02 on 01/15/25 and a 52-week low of $18.52 on 01/14/25. A 50-day SMA is recorded $23.96, while a 200-day SMA reached $23.09. Nevertheless, trading volume fell to 1.69 million shares from 0.99 million shares the previous day.

Support And Resistance Levels for Denali Therapeutics Inc (DNLI)

According to the 24-hour chart, there is a support level at 19.96, which, if violated, would cause prices to drop to 18.42. In the upper region, resistance lies at 22.53. The next price resistance is at 23.56. RSI (Relative Strength Index) is 49.27 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.54, which suggests the price will decrease in the coming days. Percent R is at 14.86%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular